These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17100683)

  • 1. Myopotentials leading to ventricular fibrillation detection after advisory defibrillator generator replacement.
    Eckart RE; Hruczkowski TW; Stevenson WG; Epstein LM
    Pacing Clin Electrophysiol; 2006 Nov; 29(11):1273-6. PubMed ID: 17100683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardiac defibrillator lead failure or myopotential oversensing? An approach to the diagnosis of noise on lead electrograms.
    Kowalski M; Ellenbogen KA; Wood MA; Friedman PL
    Europace; 2008 Aug; 10(8):914-7. PubMed ID: 18565976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Undersensing of ventricular fibrillation due to interference between a pacemaker and defibrillator in the same patient.
    Van Casteren L; Huybrechts W; Willems R
    Europace; 2009 Oct; 11(10):1390-1. PubMed ID: 19654130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular oversensing after replacement of an implantable cardioverter-defibrillator.
    Arias MA; Puchol A; Castellanos E; Pachón M; Rodríguez-Padial L
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):925-7. PubMed ID: 19572871
    [No Abstract]   [Full Text] [Related]  

  • 5. An algorithm to predict implantable cardioverter-defibrillator lead failure.
    Gunderson BD; Patel AS; Bounds CA; Shepard RK; Wood MA; Ellenbogen KA
    J Am Coll Cardiol; 2004 Nov; 44(9):1898-902. PubMed ID: 15519026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-wave oversensing by an implantable cardioverter defibrillator after successful ablation of idiopathic ventricular fibrillation.
    Strohmer B; Schernthaner C; Pichler M
    Pacing Clin Electrophysiol; 2006 Apr; 29(4):431-5. PubMed ID: 16650276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "Pain wave": P‑wave oversensing in subcutaneous ICD.
    Kattih B; Duncker D; König T; Hohmann S; Oswald H; Veltmann C
    Herzschrittmacherther Elektrophysiol; 2016 Jun; 27(2):151-3. PubMed ID: 27084342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocautery-induced ventricular fibrillation during routine implantable cardioverter-defibrillator generator replacement.
    Cassagneau R; Hanninen M; Yee R
    Europace; 2014 Mar; 16(3):319. PubMed ID: 24068449
    [No Abstract]   [Full Text] [Related]  

  • 9. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.
    Kleemann T; Becker T; Doenges K; Vater M; Senges J; Schneider S; Saggau W; Weisse U; Seidl K
    Circulation; 2007 May; 115(19):2474-80. PubMed ID: 17470696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automatic R-wave and impedance testing with the modern patient alert system to reduce inappropriate implantable cardioverter defibrillator shocks due to lead fracture.
    Chinushi M; Hosaka Y; Ikarashi N; Iijima K; Furushima H; Aizawa Y
    Europace; 2008 Jun; 10(6):738-40. PubMed ID: 18390874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early automatic remote detection of combined lead insulation defect and ICD damage.
    Neuzil P; Taborsky M; Holy F; Wallbrueck K
    Europace; 2008 May; 10(5):556-7. PubMed ID: 18227352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of T-wave oversensing with implantable cardioverter defibrillator generator replacement in an adolescent.
    Tuzcu V
    Pacing Clin Electrophysiol; 2007 Jul; 30(7):929-32. PubMed ID: 17584279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series.
    Foo D; Walker BD; Kuchar DL; Thorburn CW; Tay A; Hayward CS; Macdonald P; Keogh A; Kotlyar E; Spratt P; Jansz P
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):879-87. PubMed ID: 19572863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of bradycardia pacing and detection of ventricular fibrillation due to far-field atrial sensing in a triple chamber implantable cardioverter defibrillator.
    Vollmann D; Lüthje L; Görtler G; Unterberg C
    Pacing Clin Electrophysiol; 2002 Oct; 25(10):1513-6. PubMed ID: 12418750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple high lead impedances in an implantable-cardioverter defibrillator system: what is the mechanism?
    Ho RT
    Pacing Clin Electrophysiol; 2013 Sep; 36(9):1173-5. PubMed ID: 23594162
    [No Abstract]   [Full Text] [Related]  

  • 16. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads.
    Swerdlow CD; Gunderson BD; Ousdigian KT; Abeyratne A; Stadler RW; Gillberg JM; Patel AS; Ellenbogen KA
    Circulation; 2008 Nov; 118(21):2122-9. PubMed ID: 18981299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near-fatal incident on routine induction of ventricular fibrillation at the replacement of an implantable cardioverter defibrillator.
    Kolb C; Zrenner B; Schmitt C
    Int J Cardiol; 2006 Oct; 112(3):e74-5. PubMed ID: 16859778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of implantable defibrillator longevity under clinical circumstances: implications for device selection.
    Knops P; Theuns DA; Res JC; Jordaens L
    Pacing Clin Electrophysiol; 2009 Oct; 32(10):1276-85. PubMed ID: 19796344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.